INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Lung Cancer|Metastatic Breast Cancer|Metastatic Gastric Cancer
Interventions: DRUG: Tusamitamab ravtansine
Sponsor: Erasmus Medical Center
Collaborators: Sanofi